Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Physiol Rep ; 8(15): e14532, 2020 08.
Artigo em Inglês | MEDLINE | ID: mdl-32786064

RESUMO

Pulmonary arterial hypertension (PAH) is a syndrome diagnosed by increased mean pulmonary artery (PA) pressure and resistance and normal pulmonary capillary wedge pressure. PAH is characterized pathologically by distal pulmonary artery remodeling, increased pulmonary vascular resistance, and plexiform lesions (PLs). Right ventricular fibrosis and hypertrophy, leading to right ventricular failure, are the main determinants of mortality in PAH. Recent work suggests that right ventricular fibrosis results from resident cardiac fibroblast activation and conversion to myofibroblasts, leading to replacement of contractile cardiomyocytes with nondistensible tissue incapable of conductivity or contractility. However, the origins, triggers, and consequences of myofibroblast expansion and its pathophysiological relationship with PAH are unclear. Recent advances indicate that signals generated by adaptive and innate immune cells may play a role in right ventricular fibrosis and remodeling. This review summarizes recent insights into the mechanisms by which adaptive and innate immune signals participate in the transition of cardiac fibroblasts to activated myofibroblasts and highlights the existing gaps of knowledge as relates to the development of right ventricular fibrosis.


Assuntos
Imunidade Adaptativa , Cardiomegalia/imunologia , Hipertensão Pulmonar/complicações , Imunidade Inata , Animais , Cardiomegalia/etiologia , Cardiomegalia/patologia , Transdiferenciação Celular , Fibrose , Humanos , Macrófagos/imunologia , Macrófagos/patologia , Miofibroblastos/imunologia , Miofibroblastos/patologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...